Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia (Q35604619)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 May 2015

Language	Label	Description	Also known as
English	Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia	scientific article published on 10 May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Clinical significance of day 5 peripheral blast clearance rate in the evaluation of early treatment response and prognosis of patients with acute myeloid leukemia (English)

1 reference

Europe PubMed Central

9 August 2017

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Cong Yu

1

1 reference

Europe PubMed Central

9 August 2017

Qing-lei Kong

2

1 reference

Europe PubMed Central

9 August 2017

Yun-xiang Zhang

3

1 reference

Europe PubMed Central

9 August 2017

Xiang-qin Weng

4

1 reference

Europe PubMed Central

9 August 2017

Jing Wu

5

1 reference

Europe PubMed Central

9 August 2017

Yan Sheng

6

1 reference

Europe PubMed Central

9 August 2017

Chun-lei Jiang

7

1 reference

Europe PubMed Central

9 August 2017

Yong-mei Zhu

8

1 reference

Europe PubMed Central

9 August 2017

Qi Cao

9

1 reference

Europe PubMed Central

9 August 2017

Shu-min Xiong

10

1 reference

Europe PubMed Central

9 August 2017

Jun-min Li

11

1 reference

Europe PubMed Central

9 August 2017

Xiao-dong Xi

12

1 reference

Europe PubMed Central

9 August 2017

Sai-juan Chen

13

1 reference

Europe PubMed Central

9 August 2017

Bing Chen

14

1 reference

Europe PubMed Central

9 August 2017

publication date

10 May 2015

1 reference

Europe PubMed Central

9 August 2017

Journal of Hematology & Oncology

1 reference

Europe PubMed Central

9 August 2017

8

1 reference

Europe PubMed Central

9 August 2017

48

1 reference

Europe PubMed Central

9 August 2017

copyright license

Creative Commons Attribution 4.0 International

10 May 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s13045-015-0145-1

0 references

MRD in AML: it is time to change the definition of remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Acute myeloid leukemia: 2014 update on risk-stratification and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

The AML salad bowl

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Minimal residual disease in acute myeloid leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Anthracycline dose intensification in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

12 July 2018

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Prognostic relevance of treatment response measured by flow cytometric residual disease detection in older patients with acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

When it comes to MRD, AML ≠ ALL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4431040

25 September 2018

An introduction to ROC analysis

1 reference

https://api.crossref.org/works/10.1186%2FS13045-015-0145-1

21 January 2018

Predictive role of minimal residual disease and log clearance in acute myeloid leukemia: a comparison between multiparameter flow cytometry and Wilm's tumor 1 levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the P

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comprehensive set of idiograms representing all interpretive levels of resolution: ISCN (2009)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRD in AML: time for redefinition of CR?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25957890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13045-015-0145-1

1 reference

Europe PubMed Central

9 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35604619&oldid=1857165346"